Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer

BACKGROUND: Bromodomain and extra-terminal inhibitors (BETi) have shown efficacy for the treatment of aggressive triple negative breast cancer (TNBC). However, BETi are plagued by a narrow therapeutic window as manifested by severe toxicities at effective doses. Therefore, it is a limitation to thei...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafi, Sushmita, Camarena, Vladimir, Qureshi, Rehana, Yoon, Hyunho, Volmar, Claude-Henry, Huff, Tyler C., Sant, David W., Zheng, Lihong, Brothers, Shaun P., Wahlestedt, Claes, Slingerland, Joyce, Wang, Gaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557781/
https://www.ncbi.nlm.nih.gov/pubmed/30975544
http://dx.doi.org/10.1016/j.ebiom.2019.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557781/
https://www.ncbi.nlm.nih.gov/pubmed/30975544
http://dx.doi.org/10.1016/j.ebiom.2019.04.006

Ejemplares similares